These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The tumor microenvironment: part 1. Leibovici J; Itzhaki O; Huszar M; Sinai J Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887 [TBL] [Abstract][Full Text] [Related]
6. Endothelial Cells in the Tumor Microenvironment. Sobierajska K; Ciszewski WM; Sacewicz-Hofman I; Niewiarowska J Adv Exp Med Biol; 2020; 1234():71-86. PubMed ID: 32040856 [TBL] [Abstract][Full Text] [Related]
7. [Progress on cancer associated fibroblasts in tumor immunoregulation]. Li G; He J; Wang Q Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):558-563. PubMed ID: 30693700 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment. Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J Front Immunol; 2024; 15():1340702. PubMed ID: 38690275 [TBL] [Abstract][Full Text] [Related]
9. Innate and acquired immune surveillance in the postdissemination phase of metastasis. Gonzalez H; Robles I; Werb Z FEBS J; 2018 Feb; 285(4):654-664. PubMed ID: 29131550 [TBL] [Abstract][Full Text] [Related]
10. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
11. Three-dimensional Co-culture model for tumor-stromal interaction. Horie M; Saito A; Yamaguchi Y; Ohshima M; Nagase T J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741617 [TBL] [Abstract][Full Text] [Related]
12. The tumor microenvironment. Anderson NM; Simon MC Curr Biol; 2020 Aug; 30(16):R921-R925. PubMed ID: 32810447 [TBL] [Abstract][Full Text] [Related]
13. The fundamental role of mechanical properties in the progression of cancer disease and inflammation. Mierke CT Rep Prog Phys; 2014 Jul; 77(7):076602. PubMed ID: 25006689 [TBL] [Abstract][Full Text] [Related]
14. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Li I; Nabet BY Mol Cancer; 2019 Mar; 18(1):32. PubMed ID: 30823926 [TBL] [Abstract][Full Text] [Related]
15. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia. Li C; Liu T; Bazhin AV; Yang Y J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039 [TBL] [Abstract][Full Text] [Related]
17. Tumor and its microenvironment: a synergistic interplay. Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661 [TBL] [Abstract][Full Text] [Related]
18. miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells function. Noman MZ; Janji B; Berchem G; Chouaib S Cancer Lett; 2016 Sep; 380(1):257-62. PubMed ID: 26523672 [TBL] [Abstract][Full Text] [Related]
19. The tumour microenvironment and immune milieu of cholangiocarcinoma. Fabris L; Perugorria MJ; Mertens J; Björkström NK; Cramer T; Lleo A; Solinas A; Sänger H; Lukacs-Kornek V; Moncsek A; Siebenhüner A; Strazzabosco M Liver Int; 2019 May; 39 Suppl 1(Suppl 1):63-78. PubMed ID: 30907492 [TBL] [Abstract][Full Text] [Related]